WASHINGTON, June 30 /PRNewswire/ -- The misleading "health" halo surrounding highly-publicized marketing campaigns regarding sweetener reformulations is starting to dim.
Recent announcements by Starbucks and other brands that they will remove high fructose corn syrup from certain products are being called into question in news articles by several experts and respected journalists. These articles have poked holes in companies' marketing efforts and put forth scientifically substantiated facts about sweeteners commonly used in foods.
- As Washington Post health reporter Jennifer LaRue Huget wrote on June 12, "...most nutrition experts now agree there's really little material difference" between high fructose corn syrup and other caloric sweeteners. She added "They all deliver about 15-20 calories per teaspoon, and the human body appears not to know one from the other."(1)
- A June 25 Chicago Tribune article quoted food industry critic Walter Willett, M.D., of Harvard University's School of Public Health and author of Eat, Drink, and Be Healthy, who called recent product reformulations a "marketing distraction."(2)
- Another well-known food industry critic, Marion Nestle, commented that this type of product reformulation is a "calorie distractor." Nestle, who is the Paulette Goddard Professor of Nutrition, Food Studies and Public Health at New York University and author of What to Eat and Food Politics, continued her criticism stating, "The irony is that white table sugar -- formerly a leading target of 'eat less' messages -- suddenly has a health aura. Marketers have wasted no time moving in to use that aura to sell the same old products."(3)
"Consumers are being misled into thinking that there are nutritional differences between high fructose corn syrup and sugar, w
'/>"/>
SOURCE Corn Refiners Association Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
Nicotine dependence remains prevalent despite recent declines in cigarette use2.
Medical Safety Net in Florida to Strengthen with Recent Grants3.
Recent Survey Suggests Complications with Permanent Fillers4.
Matrixx Initiatives, Inc. Sets Time for Discussion of Recent FDA Action5.
Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack6.
Recent smoking-cessation research highlights importance of keeping teens from smoking7.
Coalition Commends Senators Baucus, Grassley for Including Prevention, Wellness of Chronic Disease in Recent Paper on Coverage Policy Options8.
Association of Flight Attendants-CWA Testifies on Emergency Planning After Recent Flu Outbreak9.
Recent developments at Burnham Institute for Medical Research, May 200910.
Cardium Reports on First Quarter 2009 Financial Results and Recent Developments11.
Dieters Dealt a Body Blow From Recent Labeling of Hydroxycut as Unsafe for Human Consumption